Cangzhou Enke Pharma-tech Co. Ltd., commonly referred to as Enke Pharma, is a leading player in the pharmaceutical and biotechnology industry, headquartered in Cangzhou, China. Established in 2003, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical intermediates and active pharmaceutical ingredients (APIs), catering to both domestic and international markets. Enke Pharma's core offerings include a diverse range of APIs and custom synthesis services, distinguished by their commitment to innovation and stringent quality control. The company has achieved notable milestones, including certifications from various international regulatory bodies, which solidify its reputation as a trusted supplier in the pharmaceutical sector. With a strong market position, Enke Pharma continues to expand its operational footprint, focusing on research and development to meet the evolving needs of the global healthcare landscape.
How does Cangzhou Enke Pharma-tech Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cangzhou Enke Pharma-tech Co. Ltd's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cangzhou Enke Pharma-tech Co. Ltd, headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Cangzhou Enke Pharma-tech may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it will be essential for the company to consider developing and communicating its climate strategies to align with global standards and expectations.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cangzhou Enke Pharma-tech Co. Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.